0001012975-11-000263.txt : 20110916 0001012975-11-000263.hdr.sgml : 20110916 20110916160428 ACCESSION NUMBER: 0001012975-11-000263 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110914 FILED AS OF DATE: 20110916 DATE AS OF CHANGE: 20110916 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NxStage Medical, Inc. CENTRAL INDEX KEY: 0001333170 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043454702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 439 SOUTH UNION STREET STREET 2: 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 BUSINESS PHONE: 978-687-4700 MAIL ADDRESS: STREET 1: 439 SOUTH UNION STREET STREET 2: 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chambon Philippe O. CENTRAL INDEX KEY: 0001192212 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51567 FILM NUMBER: 111095350 MAIL ADDRESS: STREET 1: C/O NEW LEAF VENTURE PARTNERS STREET 2: 7 TIMES SQUARE, SUITE 3502 CITY: NEW YORK STATE: NY ZIP: 10036 FORMER NAME: FORMER CONFORMED NAME: CHAMBON PHILIPPE DATE OF NAME CHANGE: 20020924 4 1 edgar.xml PRIMARY DOCUMENT X0304 4 2011-09-14 0001333170 NxStage Medical, Inc. NXTM 0001192212 Chambon Philippe O. C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 1 0 0 0 Common Stock 2011-09-14 4 S 0 20110 18.5796 D 2105587 I See footnotes See Footnote 1 in Exhibit 99.1 See Footnote 2 in Exhibit 99.1 See Footnote 3 in Exhibit 99.1 /s/ Craig L. Slutzkin as Attorney-in-fact for Philippe Chambon 2011-09-16 EX-99 2 attach_1.htm

(1) Dr. Philippe Chambon ("Chambon"), in his capacity as a member of the investment

committees of DLJCC (as defined below) and of DLJLBO (as defined below), may be deemed to

beneficially own the shares as to which this Form 4 relates. Dr. Chambon disclaims beneficial

ownership of such shares except to the extent of his pecuniary interest therein.



Sprout Capital IX, L.P. ("Sprout IX"), Sprout Capital VIII, L.P. ("Sprout VIII"), Sprout

Capital VII, L.P. ("Sprout VII"), Sprout CEO Fund, L.P. ("Sprout CEO"), Sprout Entrepreneurs

Fund, L.P. ("Sprout Entrepreneurs"), Sprout IX Plan Investors, L.P. ("IX Plan"), Sprout Plan

Investors, L.P. ("Plan Investors"), Sprout Venture Capital, L.P. ("Sprout Venture") and DLJ

ESC II, L.P. ("ESC II") are Delaware limited partnerships which make investments for long

term appreciation. DLJ Capital Corporation ("DLJCC"), a Delaware corporation acts as a

venture capital partnership management company. DLJCC is also the general partner of Sprout

CEO, Sprout Entrepreneurs and Sprout Venture. DLJCC is also the managing general partner of

Sprout IX, Sprout VIII, Sprout VII and, as such, is responsible for their day-to-day

management. DLJCC makes all of the investment decisions on behalf of Sprout IX, Sprout VIII,

Sprout VII, Sprout CEO, Sprout Entrepreneurs and Sprout Venture. DLJ Associates IX, L.P.

("Associates IX"), a Delaware limited partnership, is a general partner of Sprout IX and in

accordance with the terms of the relevant partnership agreement, does not participate in

investment decisions made on behalf of Sprout IX. DLJ Capital Associates IX, Inc. ("DLJCA

IX"), a Delaware corporation, is the managing general partner of Associates IX. DLJ

Associates VIII, L.P. ("Associates VIII"), a Delaware limited partnership, is a general

partner of Sprout VIII and in accordance with the terms of the relevant partnership

agreement, does not participate in investment decisions made on behalf of Sprout VIII. DLJ

Capital Associates VIII, Inc. ("DLJCA VIII"), a Delaware corporation, is the managing general

partner of Associates VIII. DLJ Associates VII, L.P. ("Associates VII"), a Delaware limited

partnership, is a general partner of Sprout VII and in accordance with the terms of the

relevant partnership agreement, does not participate in investment decisions made on behalf

of Sprout VII. DLJ Capital Associates VII, Inc. ("DLJCA VII"), a Delaware corporation, is the

managing general partner of Associates VII. Dr. Chambon is a limited partner of Associates

IX, Associates VIII and Associates VII. DLJ LBO Plans Management Corporation II ("DLJLBO"), a

Delaware corporation, is the general partner of IX Plan and Plan Investors and, as such, is

responsible for each of their day-to-day management. DLJLBO makes all of the investment

decisions on behalf of IX Plan and Plan Investors.



(2) Includes  (i) 19,879 shares of Common Stock sold by Sprout VII and (ii) 231 shares of

common Stock sold by Sprout CEO.



(3) Includes (i) 437,976 shares of Common Stock held directly by Sprout VIII, (ii) 21,851

shares of Common Stock held directly by Plan Investors, (iii) 37,740 shares of Common Stock

held directly by Sprout Venture, (iv) 40,414 shares of Common Stock held directly by ESC II,

(v) 1,419,013 shares of Common Stock held directly by Sprout IX, (vi) 6,665 shares of Common

Stock held directly by Sprout Entrepreneurs, (vii) 79,439 shares of Common Stock held directly

by IX Plan, (viii) 8,777 shares of Common Stock held directly by DLJCC and (x) 53,712 shares of

Common Stock held directly by Chambon.